INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 178 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,008,000 | -20.3% | 10,000 | 0.0% | 0.12% | -28.2% |
| Q3 2018 | $1,264,000 | +50.7% | 10,000 | 0.0% | 0.17% | +24.1% |
| Q2 2018 | $839,000 | +290.2% | 10,000 | +185.7% | 0.14% | +204.4% |
| Q1 2018 | $215,000 | +5.4% | 3,500 | 0.0% | 0.04% | -61.9% |
| Q4 2017 | $204,000 | -77.3% | 3,500 | -50.0% | 0.12% | -77.9% |
| Q1 2016 | $899,000 | -14.0% | 7,000 | 0.0% | 0.53% | -2.2% |
| Q4 2015 | $1,045,000 | -10.0% | 7,000 | 0.0% | 0.55% | -3.2% |
| Q3 2015 | $1,161,000 | -31.3% | 7,000 | 0.0% | 0.56% | -35.8% |
| Q2 2015 | $1,690,000 | -14.4% | 7,000 | 0.0% | 0.88% | -16.1% |
| Q1 2015 | $1,974,000 | -9.6% | 7,000 | -50.0% | 1.05% | +65.6% |
| Q4 2014 | $2,184,000 | – | 14,000 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |